[ad_1] Axsome Therapeutics Inc AXSM shares are trading higher Monday after the company received proposed labeling from the U.S. Food and Drug Administration for its treatment of major depressive disorder. Axsome Therapeutics filed a Form 8-K with the U.S. Securities and Exchange Commission showing that it received proposed labeling for its AXS-05 product candidate with respect to its New Drug Application. The company is reviewing the proposed labeling and said it will reply to the FDA to secure the final labeling agreement. Axsome Therapeutics is a biopharmaceutical company developing novel therapies for central […]

Read more